Explore
0
0
Following
0
0
Notifications
0
0
Messages
0
0
History
0
0
Favorites
0
0
Rewards
0
0
About
Contact Us
Agreement
Privacy
©
2023 32Plus CO.,LTD.
History
Clear
Try to search for users or keywords
View results for "
"
Register
Sign In
CASI-Pharmaceuticals-凯信远达
Practitioner
Lv
2
28
Followers
0
Following
CASI Pharmaceuticals, Inc. is a NASDAQ-listed biopharmaceutical company.
China
CASIPHARMACEUTICALS.COM
Established on 8/3/2012
Follow
Friend
Personal information report
ZONE
FEED
10
CONTRIBUTION
10
Videos
3
Columns
7
Their column
by time
Column
CASI And Cleave Therapeutics Announce Clinical Trial Application Approval For CB-5339 In Patients With Multiple Myeloma In China
1,900
2023-5-12
Column
CASI Pharmaceuticals’ Partner Juventas Announces New Drug Application For CNCT19 Accepted By China National Medical Products Administration
1,440
2023-5-12
Column
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS
1,696
2023-5-12
Column
CASI制药合作伙伴BIOINVENT于 ASH 2021公布BI-1206最新临床研究成果
1,377
2023-5-12
Column
CASI合作伙伴BIOINVENT宣布BI-1206获美国FDA孤儿药资格认定 治疗滤泡性淋巴瘤
1,016
2023-5-12
Column
迈入新生,维宁稳行,预见未来,亿路向前
1,248
2023-5-12
Column
CASI制药CNCT19细胞注射液获美国FDA孤儿药资格认定 正式开启全球化征程
1,304
2023-5-11
Reward
Total
Received people's reward this month
Achievement
Views
15.1K
Likes
836
Favorites
12
Silver pens
113